Elevance Health Inc. (ELV) Misses Q2 EPS by 23c, Beats on Revenue; Offers FY25 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to Elevance Health Inc. (ELV) Misses Q2 EPS by 23c, Beats on Revenue; Offers FY25 EPS Guidance

Elevance (ELV) PT Lowered to $350 at BofA Securities

July 17, 2025 12:10 PM EDT

BofA Securities analyst Kevin Fischbeck lowered the price target on Elevance (NYSE: ELV) to $350.00 (from $420.00) while maintaining a Neutral rating.

The analyst comments "Despite a Q2 in-line with company expectations, ELV cut guidance by 13%, citing higher trend in exchanges... More